Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a new MS drug help you walk better and avoid falls?

NCT ID NCT06629428

Recruiting now Disease control Sponsor: Georgia State University Source: ClinicalTrials.gov ↗

First seen Feb 12, 2026 · Last updated May 05, 2026 · Updated 7 times

Summary

This study tests whether the drug ublituximab can improve walking and reduce fall risk in 25 people with relapsing multiple sclerosis (MS). Participants will receive the treatment for 48 weeks and have their walking, balance, and thinking skills tested before, during, and after treatment. The goal is to see if the drug helps with everyday movement and safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Atlanta Neuroscience Institute

    RECRUITING

    Atlanta, Georgia, 30327, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Georgia State University

    NOT_YET_RECRUITING

    Atlanta, Georgia, 30303, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING